 | • レポートコード：QYR2104Z3033 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、イロプロスト薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（吸入、静脈内）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・イロプロスト薬の市場動向 ・企業の競争状況、市場シェア ・イロプロスト薬の種類別市場規模（吸入、静脈内） ・イロプロスト薬の用途別市場規模（病院、クリニック） ・イロプロスト薬の北米市場規模2016-2027（アメリカ、カナダ） ・イロプロスト薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・イロプロスト薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・イロプロスト薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・イロプロスト薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Actelion (J & J)、Bayer AG） ・結論 |
Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud’s phenomenon and other diseases in which the blood vessels are constricted and blood can’t flow to the tissues.
North America is estimated to have a major share in the global market with 75%.
Market Analysis and Insights: Global Iloprost Drugs Market
The global Iloprost Drugs market size is projected to reach US$ 83 million by 2026, from US$ 93 million in 2019, at a CAGR of -1.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Iloprost Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Iloprost Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Iloprost Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Iloprost Drugs market.
Global Iloprost Drugs Scope and Market Size
Iloprost Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Iloprost Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Inhaled
Intravenous
The segment of inhaled holds a comparatively larger share in global market, which accounts for about 99%.
Segment by Application
Hospital
Clinic
The hospital holds an important share in terms of applications, and accounts for 53% of the market share.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
レポート目次1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Iloprost Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Inhaled
1.2.3 Intravenous
1.3 Market by Application
1.3.1 Global Iloprost Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Iloprost Drugs Market Perspective (2016-2027)
2.2 Iloprost Drugs Growth Trends by Regions
2.2.1 Iloprost Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Iloprost Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Iloprost Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Iloprost Drugs Industry Dynamic
2.3.1 Iloprost Drugs Market Trends
2.3.2 Iloprost Drugs Market Drivers
2.3.3 Iloprost Drugs Market Challenges
2.3.4 Iloprost Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Iloprost Drugs Players by Revenue
3.1.1 Global Top Iloprost Drugs Players by Revenue (2016-2021)
3.1.2 Global Iloprost Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Iloprost Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Iloprost Drugs Revenue
3.4 Global Iloprost Drugs Market Concentration Ratio
3.4.1 Global Iloprost Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Iloprost Drugs Revenue in 2020
3.5 Iloprost Drugs Key Players Head office and Area Served
3.6 Key Players Iloprost Drugs Product Solution and Service
3.7 Date of Enter into Iloprost Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Iloprost Drugs Breakdown Data by Type
4.1 Global Iloprost Drugs Historic Market Size by Type (2016-2021)
4.2 Global Iloprost Drugs Forecasted Market Size by Type (2022-2027)
5 Iloprost Drugs Breakdown Data by Application
5.1 Global Iloprost Drugs Historic Market Size by Application (2016-2021)
5.2 Global Iloprost Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Iloprost Drugs Market Size (2016-2027)
6.2 North America Iloprost Drugs Market Size by Type
6.2.1 North America Iloprost Drugs Market Size by Type (2016-2021)
6.2.2 North America Iloprost Drugs Market Size by Type (2022-2027)
6.2.3 North America Iloprost Drugs Market Size by Type (2016-2027)
6.3 North America Iloprost Drugs Market Size by Application
6.3.1 North America Iloprost Drugs Market Size by Application (2016-2021)
6.3.2 North America Iloprost Drugs Market Size by Application (2022-2027)
6.3.3 North America Iloprost Drugs Market Size by Application (2016-2027)
6.4 North America Iloprost Drugs Market Size by Country
6.4.1 North America Iloprost Drugs Market Size by Country (2016-2021)
6.4.2 North America Iloprost Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Iloprost Drugs Market Size (2016-2027)
7.2 Europe Iloprost Drugs Market Size by Type
7.2.1 Europe Iloprost Drugs Market Size by Type (2016-2021)
7.2.2 Europe Iloprost Drugs Market Size by Type (2022-2027)
7.2.3 Europe Iloprost Drugs Market Size by Type (2016-2027)
7.3 Europe Iloprost Drugs Market Size by Application
7.3.1 Europe Iloprost Drugs Market Size by Application (2016-2021)
7.3.2 Europe Iloprost Drugs Market Size by Application (2022-2027)
7.3.3 Europe Iloprost Drugs Market Size by Application (2016-2027)
7.4 Europe Iloprost Drugs Market Size by Country
7.4.1 Europe Iloprost Drugs Market Size by Country (2016-2021)
7.4.2 Europe Iloprost Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Iloprost Drugs Market Size (2016-2027)
8.2 Asia-Pacific Iloprost Drugs Market Size by Type
8.2.1 Asia-Pacific Iloprost Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Iloprost Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Iloprost Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Iloprost Drugs Market Size by Application
8.3.1 Asia-Pacific Iloprost Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Iloprost Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Iloprost Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Iloprost Drugs Market Size by Region
8.4.1 Asia-Pacific Iloprost Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Iloprost Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Iloprost Drugs Market Size (2016-2027)
9.2 Latin America Iloprost Drugs Market Size by Type
9.2.1 Latin America Iloprost Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Iloprost Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Iloprost Drugs Market Size by Type (2016-2027)
9.3 Latin America Iloprost Drugs Market Size by Application
9.3.1 Latin America Iloprost Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Iloprost Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Iloprost Drugs Market Size by Application (2016-2027)
9.4 Latin America Iloprost Drugs Market Size by Country
9.4.1 Latin America Iloprost Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Iloprost Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Iloprost Drugs Market Size (2016-2027)
10.2 Middle East & Africa Iloprost Drugs Market Size by Type
10.2.1 Middle East & Africa Iloprost Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Iloprost Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Iloprost Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Iloprost Drugs Market Size by Application
10.3.1 Middle East & Africa Iloprost Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Iloprost Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Iloprost Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Iloprost Drugs Market Size by Country
10.4.1 Middle East & Africa Iloprost Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Iloprost Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Actelion (J & J)
11.1.1 Actelion (J & J) Company Details
11.1.2 Actelion (J & J) Business Overview
11.1.3 Actelion (J & J) Iloprost Drugs Introduction
11.1.4 Actelion (J & J) Revenue in Iloprost Drugs Business (2016-2021)
11.1.5 Actelion (J & J) Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Iloprost Drugs Introduction
11.2.4 Bayer AG Revenue in Iloprost Drugs Business (2016-2021)
11.2.5 Bayer AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Iloprost Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Inhaled
Table 3. Key Players of Intravenous
Table 4. Global Iloprost Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Iloprost Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Iloprost Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Iloprost Drugs Market Share by Regions (2016-2021)
Table 8. Global Iloprost Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Iloprost Drugs Market Share by Regions (2022-2027)
Table 10. Iloprost Drugs Market Trends
Table 11. Iloprost Drugs Market Drivers
Table 12. Iloprost Drugs Market Challenges
Table 13. Iloprost Drugs Market Restraints
Table 14. Global Iloprost Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Iloprost Drugs Market Share by Players (2016-2021)
Table 16. Global Top Iloprost Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iloprost Drugs as of 2020)
Table 17. Ranking of Global Top Iloprost Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Iloprost Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Iloprost Drugs Product Solution and Service
Table 21. Date of Enter into Iloprost Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Iloprost Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Iloprost Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Iloprost Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Iloprost Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Iloprost Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Iloprost Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Iloprost Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Iloprost Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Iloprost Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Iloprost Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Iloprost Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Iloprost Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Iloprost Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Iloprost Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Iloprost Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Iloprost Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Iloprost Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Iloprost Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Iloprost Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Iloprost Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Iloprost Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Iloprost Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Iloprost Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Iloprost Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Iloprost Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Iloprost Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Iloprost Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Iloprost Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Iloprost Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Iloprost Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Iloprost Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Iloprost Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Iloprost Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Iloprost Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Iloprost Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Iloprost Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Iloprost Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Iloprost Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Actelion (J & J) Company Details
Table 62. Actelion (J & J) Business Overview
Table 63. Actelion (J & J) Iloprost Drugs Product
Table 64. Actelion (J & J) Revenue in Iloprost Drugs Business (2016-2021) & (US$ Million)
Table 65. Actelion (J & J) Recent Development
Table 66. Bayer AG Company Details
Table 67. Bayer AG Business Overview
Table 68. Bayer AG Iloprost Drugs Product
Table 69. Bayer AG Revenue in Iloprost Drugs Business (2016-2021) & (US$ Million)
Table 70. Bayer AG Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Iloprost Drugs Market Share by Type: 2020 VS 2027
Figure 2. Inhaled Features
Figure 3. Intravenous Features
Figure 4. Global Iloprost Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Iloprost Drugs Report Years Considered
Figure 8. Global Iloprost Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Iloprost Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Iloprost Drugs Market Share by Regions: 2020 VS 2027
Figure 11. Global Iloprost Drugs Market Share by Regions (2022-2027)
Figure 12. Global Iloprost Drugs Market Share by Players in 2020
Figure 13. Global Top Iloprost Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iloprost Drugs as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Iloprost Drugs Revenue in 2020
Figure 15. Global Iloprost Drugs Revenue Market Share by Type (2016-2021)
Figure 16. Global Iloprost Drugs Revenue Market Share by Type (2022-2027)
Figure 17. North America Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Iloprost Drugs Market Share by Type (2016-2027)
Figure 19. North America Iloprost Drugs Market Share by Application (2016-2027)
Figure 20. North America Iloprost Drugs Market Share by Country (2016-2027)
Figure 21. United States Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Iloprost Drugs Market Share by Type (2016-2027)
Figure 25. Europe Iloprost Drugs Market Share by Application (2016-2027)
Figure 26. Europe Iloprost Drugs Market Share by Country (2016-2027)
Figure 27. Germany Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Iloprost Drugs Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Iloprost Drugs Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Iloprost Drugs Market Share by Region (2016-2027)
Figure 37. China Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Iloprost Drugs Market Share by Type (2016-2027)
Figure 45. Latin America Iloprost Drugs Market Share by Application (2016-2027)
Figure 46. Latin America Iloprost Drugs Market Share by Country (2016-2027)
Figure 47. Mexico Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Iloprost Drugs Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Iloprost Drugs Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Iloprost Drugs Market Share by Country (2016-2027)
Figure 53. Turkey Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Iloprost Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Actelion (J & J) Revenue Growth Rate in Iloprost Drugs Business (2016-2021)
Figure 57. Bayer AG Revenue Growth Rate in Iloprost Drugs Business (2016-2021)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
世界の不妊症治療薬市場規模・現状・予測（2021年-2027年） Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins. Market compet…- 世界のコリン作動薬市場規模・現状・予測（2021年-2027年） Cholinergic drug, any of various drugs that inhibit, enhance, or mimic the action of the neurotransmitter acetylcholine, the primary transmitter of nerve impulses within the parasympathetic nervous system. Market Analysis and Insights: Global Cholinergic Drugs Market The global Cholinergic Drugs mar…
- 世界のチロシンヒドロキシラーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- 世界のチロシンヒドロキシラーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- 世界のバーター症候群治療薬市場規模・現状・予測（2021年-2027年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% du…